首頁 > 市場調查報告書 > 消費品

寵物產品

市場調查報告書

商品編碼

1448742

全球寵物照護糖尿病藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Pet Care Diabetes Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球寵物照護糖尿病藥物市場需求預計將從 2023 年的 750.11 萬美元達到 2032 年近 1429.73 萬美元的市場規模，2024-2032 年研究期間CAGR為 7.43%。

寵物照顧糖尿病藥物市場涉及治療影響寵物（包括狗和貓）的糖尿病的藥物。寵物糖尿病是一種可以透過藥物、胰島素治療和飲食改變來控制的疾病，就像人類一樣。獸醫可能會開立胰島素和其他旨在調節血糖水平的藥物來控制寵物的糖尿病。

市場動態

寵物照護糖尿病藥物市場受到多種因素的推動，導致對專業獸藥的需求增加。全球寵物趨勢的不斷成長是一個重要的推動因素，越來越多的人將寵物視為不可或缺的家庭成員。寵物主人對動物健康，特別是糖尿病等疾病的認知不斷提高，導致診斷率提高，並願意尋求先進的治療方法。獸醫學的不斷進步，包括開發新的和更有效的藥物，有助於市場的成長。寵物的人性化以及對其醫療保健的投資意願不斷增強，進一步推動了針對動物的糖尿病藥物的需求。藥物配方、給藥方法和監測設備的創新，以及獸醫保健基礎設施的改進，在加強寵物糖尿病的診斷和管理方面發揮關鍵作用。製藥公司、獸醫診所和研究機構之間的合作，加上支持性法規，也有助於寵物照護糖尿病藥物市場的動態擴張。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球寵物照護糖尿病藥物市場的各個細分市場進行了包容性評估。寵物照護糖尿病藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

寵物照護糖尿病藥物市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

胰島素藥物
SGLT2 抑制劑
其他

依動物類型

貓
小狗

按最終用戶

獸醫醫院藥房
零售藥局
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲寵物護理糖尿病藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。寵物照護糖尿病藥物市場的主要參與者包括勃林格殷格翰國際有限公司、Elanco、默克動物保健公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：寵物照護糖尿病藥物公司的競爭格局

寵物照護糖尿病藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Boehringer Ingelheim International GmbH

公司簡介
公司收入
產品
最近的發展

Elanco

公司簡介
公司收入
產品
最近的發展

Merck Animal Health

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113598

The global demand for Pet Care Diabetes Drugs Market is presumed to reach the market size of nearly USD 1429.73 MN by 2032 from USD 750.11 MN in 2023 with a CAGR of 7.43% under the study period 2024 - 2032.

The Pet Care Diabetes Drugs market involves drugs that treat diabetes mellitus affecting pets, including dogs and cats. Diabetes in pets is a condition that may be managed with medications, insulin therapy, and dietary changes, much like in humans. Insulin and other medications designed to regulate blood sugar levels may be prescribed by veterinarians to manage diabetes in pets.

MARKET DYNAMICS

The Pet Care Diabetes Drugs market is driven by various factors contributing to the increased demand for specialized veterinary pharmaceuticals. The growing global trend of pet ownership is a significant driver, with more individuals considering pets as integral family members. Rising awareness among pet owners regarding animal health, particularly conditions like diabetes, has led to higher diagnosis rates and a willingness to seek advanced treatments. Ongoing advancements in veterinary medicine, including the development of new and more effective drugs, contribute to market growth. The humanization of pets and the increasing willingness to invest in their healthcare further boost the demand for diabetes drugs tailored for animals. Innovations in drug formulations, delivery methods, and monitoring devices, along with improvements in veterinary healthcare infrastructure, play key roles in enhancing the diagnosis and management of diabetes in pets. Collaborations between pharmaceutical companies, veterinary clinics, and research institutions, coupled with supportive regulations, also contribute to the dynamic expansion of the pet care diabetes drugs market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pet care diabetes drugs. The growth and trends of pet care diabetes drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pet care diabetes drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Insulin Drugs
SGLT2 Inhibitors
Others

By Animal Type

Cats
Dogs

By End-User

Vet Hospital Pharmacies
Retail Pharmacies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pet Care Diabetes Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pet Care Diabetes Drugs market include Boehringer Ingelheim International GmbH, Elanco, Merck Animal Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PET CARE DIABETES DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Animal Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Insulin Drugs Historic and Forecast Sales by Regions
5.5 SGLT2 Inhibitors Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY ANIMAL TYPE

6.1 Overview by Animal Type
6.2 Historical and Forecast Data
6.3 Analysis by Animal Type
6.4 Cats Historic and Forecast Sales by Regions
6.5 Dogs Historic and Forecast Sales by Regions

7 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Vet Hospital Pharmacies Historic and Forecast Sales by Regions
7.5 Retail Pharmacies Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PET CARE DIABETES DRUGS COMPANIES

9.1. Pet Care Diabetes Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PET CARE DIABETES DRUGS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Boehringer Ingelheim International GmbH
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Elanco
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Merck Animal Health
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments